These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16610967)

  • 1. Mitochondrial disease in the offspring as a result of antiretroviral therapy.
    Venhoff N; Walker UA
    Expert Opin Drug Saf; 2006 May; 5(3):373-81. PubMed ID: 16610967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?
    Thorne C; Newell ML
    Drug Saf; 2007; 30(3):203-13. PubMed ID: 17343429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues.
    Thorne C; Newell ML
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):425-36. PubMed ID: 15010553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial disorders among infants exposed to HIV and antiretroviral therapy.
    Funk MJ; Belinson SE; Pimenta JM; Morsheimer M; Gibbons DC
    Drug Saf; 2007; 30(10):845-59. PubMed ID: 17867723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals.
    Noguera A; Fortuny C; Muñoz-Almagro C; Sanchez E; Vilaseca MA; Artuch R; Pou J; Jimenez R
    Pediatrics; 2004 Nov; 114(5):e598-603. PubMed ID: 15492359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zidovudine administration during pregnancy and mitochondrial disease in the offspring.
    Tovo PA; Chiapello N; Gabiano C; Zeviani M; Spada M
    Antivir Ther; 2005; 10(6):697-9. PubMed ID: 16218167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental Mitochondrial Toxicity, Oxidative Stress, Apoptosis, and Adverse Perinatal Outcomes in HIV Pregnancies Under Antiretroviral Treatment Containing Zidovudine.
    Hernández S; Catalán-García M; Morén C; García-Otero L; López M; Guitart-Mampel M; Milisenda J; Coll O; Cardellach F; Gratacós E; Miró Ò; Garrabou G
    J Acquir Immune Defic Syndr; 2017 Aug; 75(4):e113-e119. PubMed ID: 28234688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety of highly active antiretroviral therapy for the HIV-positive pregnant mother and her baby: is 'the more the merrier'?
    Martin F; Taylor GP
    J Antimicrob Chemother; 2009 Nov; 64(5):895-900. PubMed ID: 19706669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy.
    Alimenti A; Burdge DR; Ogilvie GS; Money DM; Forbes JC
    Pediatr Infect Dis J; 2003 Sep; 22(9):782-9. PubMed ID: 14506368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal consequences of maternal antiretroviral nucleoside reverse transcriptase inhibitor use in human and nonhuman primate pregnancy.
    Poirier MC; Gibbons AT; Rugeles MT; Andre-Schmutz I; Blanche S
    Curr Opin Pediatr; 2015 Apr; 27(2):233-9. PubMed ID: 25635584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.
    Brogly SB; Ylitalo N; Mofenson LM; Oleske J; Van Dyke R; Crain MJ; Abzug MJ; Brady M; Jean-Philippe P; Hughes MD; Seage GR
    AIDS; 2007 May; 21(8):929-38. PubMed ID: 17457086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety of antiretroviral drugs in pregnancy.
    Thorne C; Newell ML
    Expert Opin Drug Saf; 2005 Mar; 4(2):323-35. PubMed ID: 15794723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperlactatemia and in utero exposure to antiretrovirals: is the control group the clue?
    Soler-Palacín P; Martín-Nalda A; Martínez-Gómez X; Melendo S; Riudor E; Arranz JA; Espiau M; Figueras C
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):752-8. PubMed ID: 22010980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers.
    Poirier MC; Divi RL; Al-Harthi L; Olivero OA; Nguyen V; Walker B; Landay AL; Walker VE; Charurat M; Blattner WA;
    J Acquir Immune Defic Syndr; 2003 Jun; 33(2):175-83. PubMed ID: 12794551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
    Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J
    JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV: Agence Nationale de Recherches Sur le SIDA et les Hépatites Virales 1209 study, Abidjan, Ivory Coast.
    Ekouevi DK; Touré R; Becquet R; Viho I; Sakarovitch C; Rouet F; Towne-Gold B; Fassinou P; Leroy V; Blanche S; Dabis F;
    Pediatrics; 2006 Oct; 118(4):e1071-7. PubMed ID: 16950945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
    Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
    Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tolerance of antiretroviral drugs during pregnancy].
    Blanche S; Warszawski J
    Med Sci (Paris); 2013 Apr; 29(4):383-8. PubMed ID: 23621933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.
    Sibiude J; Le Chenadec J; Bonnet D; Tubiana R; Faye A; Dollfus C; Mandelbrot L; Delmas S; Lelong N; Khoshnood B; Warszawski J; Blanche S;
    Clin Infect Dis; 2015 Jul; 61(2):270-80. PubMed ID: 25838291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.